Related Experiment Videos
Correlation between secretion pattern and metastatic potential from drug-treated 3LL tumor cell line
M C Barbero1, M Garcia, A Almena
1Departamento de Biología Celular y Ciencias Morfológicas, Universidad del País Vasco, Leioa, Vizcaya, Spain.
Cellular and Molecular Biology
|January 1, 1991
Summary
Three drugs (A23187, indomethacin, PMA) increased secreted proteins and enhanced metastasis in 3LL tumor cells. This study confirms high-performance gel permeation chromatography (HPGPC) can link secretion patterns to metastatic potential.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- The metastatic potential of cancer cells is a critical determinant of patient prognosis.
- Understanding the molecular mechanisms underlying metastasis is crucial for developing effective therapies.
- Cancer cell secretion patterns may offer insights into their metastatic capabilities.
Purpose of the Study:
- To investigate the effects of A23187 calcium ionophore, indomethacin, and phorbol myristate acetate on the secretion profile and metastatic potential of the 3LL tumor cell line.
- To evaluate the utility of high-performance gel permeation chromatography (HPGPC) in distinguishing between low and high metastatic potential based on secretion patterns.
- To establish a correlation between drug-induced alterations in secretion patterns and changes in metastatic potential.
Main Methods:
- Treatment of the low metastatic 3LL tumor cell line with three different drugs: A23187 calcium ionophore, indomethacin, and phorbol myristate acetate.
- Analysis of secreted protein fractions using high-performance gel permeation chromatography (HPGPC).
- Assessment of in vivo metastatic rate of drug-treated and untreated 3LL cells.
Main Results:
- Drug-treated 3LL cells consistently secreted higher amounts of a low molecular weight protein fraction compared to untreated cells.
- All three tested drugs significantly enhanced the in vivo metastatic rate of the 3LL cells.
- HPGPC analysis of secretion patterns effectively discriminated between low and high metastatic potential, confirming earlier findings.
Conclusions:
- Alterations in the cellular secretion pattern are associated with changes in the metastatic potential of 3LL tumor cells.
- The studied drugs not only modify the secretion profile but also increase the metastatic capability of cancer cells.
- HPGPC is a valuable tool for analyzing cancer cell secretion patterns and predicting metastatic potential.